Substance use disorder (SUD) is a chronic, relapsing disease with a highly multifaceted
pathology that includes (but is not limited to) sensitivity to drug-associated cues, negative …

Methamphetamine‐associated cardiomyopathy (MACM) is an increasingly recognized
disease entity in the context of a rapidly spreading methamphetamine epidemic. MACM may …

Background Polydrug use may challenge effective treatment for substance use disorders.
We evaluate whether secondary substance use modifies the association between treatment …

Millions of people around the world drink alcoholic beverages to cope with the stress of
modern lifestyle. Although moderate alcohol drinking may have some relaxing and euphoric …

Preclinical models of addictive drugs have been developed for decades to model aspects of
the clinical experience in substance use disorders (SUDs). These include passive exposure …

Background Methamphetamine use disorder (MUD) frequently begins in adolescence, often
accompanied by other psychiatric or mental disorders. Up to now, no comprehensive review …

Alcohol consumption with psychostimulants is very common among drug addicts. There is
little known about the possible pharmacological interactions between alcohol and …

In this work, a novel raft-like structure that combines noble metal nanoparticles (NPs) with an
interconnected layer of hemispherical dielectric shell was fabricated and characterized. It …

Exposure to ethanol (EtOH) or methamphetamine (MA) can lead to increase in extracellular
glutamate concentration in the brain. Although studies from ours showed the effects of EtOH …

A significant comorbidity exists between alcohol and methamphetamine (Meth) abuse but
the neurochemical consequences of this co‐abuse are unknown. Alcohol and Meth …